DL-Homocystine,DL-Homocysteine Thiolactone Hydrocloride,N-Chloroacetyl Homocysteine Thiolactone,DL-2-Chloro-phenylglycine,DL-4-Chloro-phenylglycine,Tetrazolyl Acetic Acid(TAA),1H-Tetrazole-5-Carboxylic Acid(ETC),Erdosteine,Citiolone,4,4'-Sulfonyldiphenol(BPS),4,4'-dichlorophenyl sulfone,4-Tert-Butylphenylacetonitrile,Diethylaminohydroxybenzoyl hexyl benzoate(DHHB)
more >
Year of Establishment:
2005
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company,Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: